Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Sets Financial Goals For 2024 And 2028

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    16/06/2023 08:50
    June 16 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * SETS FINANCIAL GOALS FOR 2024 AND 2028
    * BY 2028, COMPANY EXPECTS TO ACHIEVE SALES OF SEK 350 MILLION
    * GOAL FOR EBITDA IS AN OPERATING MARGIN OF 20% IN 2028 AND IN 2024 TO ACHIEVE A POSITIVE
QUARTERLY EBITDA
    * NEW GOALS ARE REPLACING GOALS ANNOUNCED EARLY 2022
    * INCREASING SALES OPPORTUNITIES FROM LAUNCH OF NEW PRODUCTS DURING 2023 AND EFFICIENT
DEPLOYMENT
OF RESOURCES, WILL CONTRIBUTE TO TURNING EBITDA POSITIVE ON A QUARTERLY BASIS DURING 2024

Source text for Eikon:  ID:nMFN4ZMC8V 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news